20
“If we fail to give people with diabetes the long and healthy lives we are capable of giving them, we will not be forgiven.” Bill Clinton, US President, 1993-2001 Keynote lecture at the ‘Global Changing Diabetes Leadership Forum’, New York, 2007

Curalife -קיורהלייף - מי אנחנו

Embed Size (px)

Citation preview

Page 1: Curalife  -קיורהלייף - מי אנחנו

“If we fail to give people with diabetes the long and healthy lives we are capable of giving them, we will not be forgiven.”

Bill Clinton, US President, 1993-2001Keynote lecture at the ‘Global Changing Diabetes Leadership Forum’, New York, 2007

Page 2: Curalife  -קיורהלייף - מי אנחנו

Natural Wellbeing Global

Our Vision

CuraLife is a nutritional supplement company that targets wellness and a healthier future for sufferers of chronic illness through natural, non-prescription remedies.

Our goal is to become a Category Champion in the mass market, consumer healthcare market for non-prescription, scientifically proven products.

Page 3: Curalife  -קיורהלייף - מי אנחנו

Who Are We?

Trials and usage show efficacy and quick results

ProvenA vision to

make the world a better, healthier place

Responsible

Increase efficacy and

new products in

development

Innovative

Advisory board with recognized

industry professionals

Trusted

Exclusive rights in major markets with

a global exclusive right

Global

Page 4: Curalife  -קיורהלייף - מי אנחנו

R&D

Our advanced R&D facility, situated on London, combines knowledge of traditional ancient effective remedies together with modern research, extraction and development capabilities bringing best in class, safe and effective products. 

Page 5: Curalife  -קיורהלייף - מי אנחנו

Management Team

Rafi Elul

ChairmanRafi is CEO of the strategic consulting and ventures firm ISHRA. He served two terms in the national Parliament and continues to advise the offices of President and PM. He is Chairman of the national volunteer program ‘Ruach Tova’.

Ron Elul

Chief Executive OfficerRon heads business development activity with successful track record marketing and innovative start-ups. He maintains responsibility for project design, development and penetrating new markets worldwide.

Ofer Yigdal

Chief Operating OfficerOfer is responsible for key accounts, service delivery and operational efficiency. As an experienced marketing professional, he has worked with many of the major health and wellness brands in Israel and has experience of both channel and product marketing.

CEO COOCHAIR VP

Henry Yahav

VP Sales & MarketingHenry has been working in the supplement industry for over 25 years. As former MD for Herbalife Israel and Juice Plus. Henry also has experience in the international market with brands including NSA Swiss, Morinda and is practiced at developing robust sales networks.

Page 6: Curalife  -קיורהלייף - מי אנחנו

Advisory Board

Dr. Sara Kaplan

Dr. Sara Kaplan is a clinical dietitian and leading diet expert. With over 30 years of working practice, she heads Department of Human Nutrition and Diet at Meuhedet, one of the Israel’s largest private healthcare providers and Nutritional Science at the Peres Academic Center in Rehovot. She holds a Ph.D in Clinical Epidemiology from Tel-Aviv University.

Dr. Uri Eliyahu

Dr. Eliyahu has a Ph.D in Medical Sciences specializing in Epidemiology. As a licensed pharmacist he holds an MSc in Physiology and Pharmacology from Tel Aviv University (cum laude). He is Editor in Chief of the Israeli National Pharmacist magazine and a leading lecturer in many of Israel’s top universities.

Page 7: Curalife  -קיורהלייף - מי אנחנו

New Battleground – Consumer Healthcareo A new consumer healthcare segment is emergingo Healthcare products will move to the heart of the mass marketo Room to grow the brand + opportunity to exit

Page 8: Curalife  -קיורהלייף - מי אנחנו

o Global prevalence of raised cholesterol among adults (≥ 5.0 mmol/l) was 39% (2008).

o One third of ischaemic heart disease is attributable to high cholesterol.

o Estimated to cause 2.6 million deaths (4.5% of total).

o 29.7 million (2%) of disability adjusted life years (DALYS).

o A 10% reduction in serum cholesterol in men aged 40 can reduce heart disease by 50% within 5 years.

o In high-income countries, over 50% of adults had raised total cholesterol.

Source: WHO estimates Global Health Observatory,

Pipeline – Large Addressable Markets

o 300 million asthma sufferers worldwide.

o Number of asthmatics will grow by more than 100 million by 2025.

o 250,000 annual deaths – almost all are avoidable.

o 70% of asthmatics also have allergies.

o World-wide, the economic costs associated with asthma are estimated to exceed those of TB and HIV/AIDS combined.

Source: World Health Organization. Global surveillance…,

o Globally, nearly one billion people have high blood pressure (hypertension).

o Raised blood pressure causes 7.5 million deaths (12.8% of total deaths).

o Accounts for 57 million (3.7%) disability adjusted life years (DALYS).

o Blood pressure levels are shown to be positively and continuously. related to the risk for stroke and coronary heart disease.

o Globally, raised blood pressure in adults 25+ is around 40% (2008)

Source: WHO estimates Global Health Observatory, World Heart Federation

Page 9: Curalife  -קיורהלייף - מי אנחנו
Page 10: Curalife  -קיורהלייף - מי אנחנו

Diabetes – the Basics

Source: http://www.idf.org/diabetesatlas/5e/the-global-burden

Page 11: Curalife  -קיורהלייף - מי אנחנו

Diabetes – Impact on Body

Page 12: Curalife  -קיורהלייף - מי אנחנו

A Global Epidemic

Source: http://www.idf.org/diabetesatlas/5e/the-global-burden

Page 13: Curalife  -קיורהלייף - מי אנחנו

Diabetes Market Overview

In 2013, 382 million people were diagnosed diabetics; by 2035 this will rise

to 592 million.

183 million people (50%) with diabetes are undiagnosed

Diabetes caused 4.6 million deaths in 2011

Diabetes caused at least $458 billion in healthcare expenditure in 2013 

11% of total healthcare expenditure in adults (20-79 years)

$

2013

2035

382M

592M

+55%

Page 14: Curalife  -קיורהלייף - מי אנחנו

Diabetes - Impact on Healthcare

o WHO estimates one patient with diabetes dies every 6 seconds worldwide (2013) or 5.1 million deaths.

o Global health spending to treat diabetes and manage complications totalled at least $548 billion in 2013.

o 76% of global health expenditure on diabetes in 2013 was for people between the ages of 50 and 79 years.

o An estimated average of $1,437 per person with diabetes was spent globally on treating and managing the disease in 2013.

o In high income countries spend was $5,621 per person compared with $356 in low-middle income countries.

Source: http://www.idf.org/diabetesatlas/5e/the-global-burden

Page 15: Curalife  -קיורהלייף - מי אנחנו

Product Information

Page 16: Curalife  -קיורהלייף - מי אנחנו

CuraLin - Product Efficacyo Within 3-5 days users can expect to see a dramatic change in blood sugar

levels. After just one month we expect to see a significant reduction as well as an improvement in the overall health of users.

o Results showed the product was successful in improving glycemic control in patients.

o Recognizable ingredients with evidence of blood sugar reduction properties.

Page 17: Curalife  -קיורהלייף - מי אנחנו

Patient Impacto The application of Ayurveda practice combined with the

scientific knowledge of 21st Century medicine creates a dramatic impact on the reduction of sugar levels produced in the body.

o The formula reactivates and strengthens the pancreas which is responsible for the production of insulin in the body.

o Blood sugar levels reduced with attention given to the overall balance of the body.

o Clear Benefits:o Helps lower and control blood sugar levelso Reactivates and strengthens the pancreaso Helps with blurred visiono Removes any tingling sensation o Boosts energy levelso Reduces dependency on allopathic medicationo Completely herbal

Page 18: Curalife  -קיורהלייף - מי אנחנו

Customer Feedback (1)A customer survey was conducted by phone in April 2014 with data from an uncontrolled sample group of 50 product users.

o Average age 61

o Male 66% : Female 34%

o Average length of product use 3.1 years

o 44% take no other form of diabetic treatment

% reduction after 3 months use

% reduction till today

Users 6 - 7.9 mmol/l 8.5% 10.7%

Users 8+ mmol/l 18.6% 24.4%

Total 13.3% 17.3%

Page 19: Curalife  -קיורהלייף - מי אנחנו

Customer Feedback (2)How satisfied are you with the

performance of the Supplement?I am confident in my ability to manage my

blood sugar levels?

How big an impact has it had on your lifestyle?

Would you recommend the supplement to anyone else?

Big Impact 84%%

Some Impact 14%

Neutral2%

Confident 13%

Very Confident 84%

Neutral3%

Yes 100%

Very Satisfied 94%

Satisfied 6%

Page 20: Curalife  -קיורהלייף - מי אנחנו

Thank You – Ron Elul | +972 506 724 208 | [email protected]